drugset / Trial / NCT06082440

Study on the Safety and Tolerance of Mesenchymal Stem Cells Mediated by Arthroscopy in Patients With Osteoarthritis

NCT06082440 ↗

NaSingle-groupOpen-labelTreatment

Summary

The goal of this clinical trial is to evaluate the safety and tolerability of human umbilical cord mesenchymal stem cells mediated by arthroscopy in patients with knee osteoarthritis. This experiment proposes to enroll 18-22 patients. The experimental drug is human umbilical cord mesenchymal stem cells.

Timeline

Start
2023-11-22
Primary completion
2025-08-15
Completion
2026-01-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Human Umbilical Mesenchymal Stem Cells Cell therapy 2.5e+07 cells Other

Indications